Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Prepaid Assets readings, the most recent being $1.1 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 150.22% to $1.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 million, a 150.22% increase, with the full-year FY2025 number at $5.9 million, up 1071.49% from a year prior.
  • Prepaid Assets hit $1.1 million in Q1 2026 for Catalyst Pharmaceuticals, down from $5.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $23.6 million in Q2 2024 to a low of $452000.0 in Q1 2025.
  • Median Prepaid Assets over the past 5 years was $4.3 million (2022), compared with a mean of $5.7 million.
  • The widest YoY moves for Prepaid Assets: up 1071.49% in 2025, down 96.71% in 2025.
  • Catalyst Pharmaceuticals' Prepaid Assets stood at $5.2 million in 2022, then tumbled by 74.22% to $1.3 million in 2023, then tumbled by 62.09% to $505000.0 in 2024, then skyrocketed by 1071.49% to $5.9 million in 2025, then tumbled by 80.88% to $1.1 million in 2026.
  • The last three reported values for Prepaid Assets were $1.1 million (Q1 2026), $5.9 million (Q4 2025), and $540000.0 (Q3 2025) per Business Quant data.